Literature DB >> 31049336

The Higher Number and Longer Duration of Kenogen Hairs Are the Main Cause of the Hair Rarefaction in Androgenetic Alopecia.

Marcella Guarrera1, Alfredo Rebora1.   

Abstract

The progressive reduction of the number of terminal hairs and the simultaneous increase in the number of vellus hairs (hair miniaturization) are the current explanation of human baldness. In a 2.5-year study on 43 male subjects with androgenetic alopecia (AGA), we found that oral finasteride augmented the total number of hairs by 55%, but failed to decrease the prevalence of vellus hairs. While our data may explain why, in AGA, hairs become progressively softer and combable, they cannot explain why areas of hair rarefaction develop. We propose that the longer duration and higher frequency of kenogen hairs are the real mechanism through which the scalp hairs rarefy.

Entities:  

Keywords:  Androgenetic alopecia; Baldness; Finasteride; Hair cycle; Kenogen

Year:  2018        PMID: 31049336      PMCID: PMC6489042          DOI: 10.1159/000493587

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  8 in total

1.  Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair.

Authors:  D Hugh Rushton; Michael J Norris; Dominique Van Neste
Journal:  Exp Dermatol       Date:  2016-04-12       Impact factor: 3.960

2.  Androgenetic alopecia. Modelling progression and regrowth.

Authors:  Rodney Sinclair
Journal:  Exp Dermatol       Date:  2016-06       Impact factor: 3.960

3.  Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.

Authors:  Vera H Price; Emory Menefee; Matilde Sanchez; Keith D Kaufman
Journal:  J Am Acad Dermatol       Date:  2006-05-03       Impact factor: 11.527

4.  Finasteride increases anagen hair in men with androgenetic alopecia.

Authors:  D Van Neste; V Fuh; P Sanchez-Pedreno; E Lopez-Bran; H Wolff; D Whiting; J Roberts; D Kopera; J J Stene; S Calvieri; A Tosti; E Prens; M Guarrera; P Kanojia; W He; K D Kaufman
Journal:  Br J Dermatol       Date:  2000-10       Impact factor: 9.302

5.  Kenogen in female androgenetic alopecia. A longitudinal study.

Authors:  M Guarrera; A Rebora
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

6.  Delayed telogen replacement in a boy's scalp.

Authors:  M Guarrera; C Cipriani; A Rebora
Journal:  Dermatology       Date:  1998       Impact factor: 5.366

7.  Kenogen. A new phase of the hair cycle?

Authors:  Alfredo Rebora; Marcella Guarrera
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

8.  Hair cycle and alopecia.

Authors:  M Courtois; G Loussouarn; C Hourseau; J F Grollier
Journal:  Skin Pharmacol       Date:  1994
  8 in total
  2 in total

1.  Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question.

Authors:  Alfredo Rebora; Marcella Guarrera
Journal:  Skin Appendage Disord       Date:  2021-05-06

2.  Following historical "tracks" of hair follicle miniaturisation in patterned hair loss: Are elastin bodies the forgotten aetiology?

Authors:  D Hugh Rushton; Gillian E Westgate; Dominique J Van Neste
Journal:  Exp Dermatol       Date:  2021-06-11       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.